Table 1 Characteristics of the analyzed patients with DCM after 5 years
PARAMETER | Mean ± SD or number of patients (%) |
|---|---|
Age (years) | 59.0 ± 11.0 |
Gender (male) | 40 (89) |
NYHA class | |
I | 4 (9) |
II | 22 (49) |
III | 15 (33) |
IV | 4 (9) |
Atrial fibrillation | 15 (33) |
Hypercholesterolemia | 20 (46) |
Anemia* | 4 (9) |
Diabetes mellitus or abnormal glucose level | 9 (20) |
LV diastolic dysfunction | 4 (9) |
sPAP >40 mmHg | 4 (9) |
MR degree | |
0 | 7 (15) |
I | 19 (43) |
II | 15 (34) |
III | 4 (9) |
TR degree | |
0 | 23 (51) |
I | 14 (32) |
II | 8 (17) |
PHARMACOLOGICAL TREATMENT | |
Loop diuretics | 41 (91) |
Spironolactone/eplerenone | 39 (87) |
vBeta-blockers | 40 (88) |
ACE inhibitors | 41 (91) |
Sartans (ARBs) | 4 (9) |
Digoxin | 15 (34) |
Acenocoumarol/warfarin | 9 (20) |
Amiodarone | 4 (8) |
Statins | 22 (49) |
Insulin | 2 (4) |
Oral hypoglycemics | 4 (9) |